Received Apr 22, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | EK225 | RA |
acute shingles; This non-serious case was reported by a physician via sales rep and described the occurrence of shingles in a 59-year-old female patient who received Herpes zoster (Shingrix) (batch number EK225) for prophylaxis. The patient's past medical history included stye (seen in the office on 14th March 2025 with stye on the right eye and referred to ophthalmologist). On 27-MAR-2025, the patient received the 1st dose of Shingrix (right deltoid) .5 ml. On an unknown date, an unknown time after receiving Shingrix, the patient experienced shingles (Verbatim: acute shingles). The patient was treated with prednisone acetate (Prednisone), hydrocodone bitartrate (Hydrocodone), valaciclovir hydrochloride (Valacyclovir) and gabapentin. The outcome of the shingles was not reported. It was unknown if the reporter considered the shingles to be related to Shingrix. It was unknown if the company considered the shingles to be related to Shingrix. Additional Information: GSK receipt date: 16-APR-2025 The first dose of vaccine was given on 27th March 2025 in the right deltoid. The patient was seen the urgent care on 2nd April 2025 and was diagnosed with acute shingles. She was previously seen in the office on 14th March 2025 with complaints of a stye on the right eye and referred to ophthalmologist. The shingles rash was actually on the left side of the face and the neck and then the urgent care on 2nd April 2025 was prescribed prednisone, hydrocodone, and valacyclovir and also gabapentin. She was 59 years old, and she was not having any further complications at this time the last office visit again was 2nd April 2025.
Medical History/Concurrent Conditions: Stye (seen in the office on 14th March 2025 with stye on the right eye and referred to ophthalmologist)